MedPath

Clinical Study of the Topcon Pachymeter TRK-3 to Evaluate Agreement and Precision

Completed
Conditions
Corneal Thickness
Interventions
Device: SP-1P
Registration Number
NCT05283343
Lead Sponsor
Topcon Corporation
Brief Summary

Agreement and Precision of corneal thickness measurement (pachymetry) function of the test device TRK-3 and the predicate device SP-1P will be evaluated in volunteers, and safety will be evaluated.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  1. Individuals who gave written informed consent to participate in the clinical trial by their free will.
  2. Individuals who aged 20 years or older at the time of informed consent
  3. Individuals who were deemed eligible for the study by the investigator for screening prior to enrollment.
  4. Subjects who are able to comply with compliance items during participation in the clinical trial, undergo medical examination and examination specified in the protocol, and report subjective symptoms, etc.
Exclusion Criteria
  1. Individuals with ocular diseases that may affect corneal thickness measurement (blindness, corneal perforation, bullous keratopathy, nystagmus, etc.) or who have a history of ocular diseases and are considered by the investigator to be ineligible for participation in the study.
  2. Individuals who have or are suspected of suffering from ocular or systemic infections.
  3. Other persons who are judged by the investigator to be unfavorable candidates for the study.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Adults 20 years old or olderSP-1P-
Primary Outcome Measures
NameTimeMethod
Corneal thickness1 day

Corneal thickness

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Samoncho Clinic

🇯🇵

Tokyo, Japan

© Copyright 2025. All Rights Reserved by MedPath